The Zhitong Finance App learned that the second-quarter results announced by LLY.US (LLY.US) ahead of the market on Wednesday were better than market expectations, mainly due to strong sales of its injectable GLP-1 drug and the newly marketed oral diet drug FoundAyo. As of press time, the company was up 5%.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.